Detalhe da pesquisa
1.
Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study.
BMC Pulm Med
; 19(1): 146, 2019 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409396
2.
Abnormal social behavior in mice with tyrosinemia type I is associated with an increase of myelin in the cerebral cortex.
Metab Brain Dis
; 32(6): 1829-1841, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28712060
3.
A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease.
Mol Pharm
; 13(3): 863-72, 2016 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26833139
4.
Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice.
J Inherit Metab Dis
; 39(5): 673-682, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27271696
5.
Kir1.1 (ROMK) and Kv7.1 (KCNQ1/KvLQT1) are essential for normal gastric acid secretion: importance of functional Kir1.1.
Pflugers Arch
; 467(7): 1457-1468, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25127675
6.
Glucose stimulates calcium-activated chloride secretion in small intestinal cells.
Am J Physiol Cell Physiol
; 306(7): C687-96, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24477233
7.
Patient Opinions and Side Effects Before and After General Anesthesia for Surgery.
Cureus
; 16(2): e53755, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38465100
8.
WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion.
Nat Genet
; 35(4): 372-6, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14608358
9.
Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation.
Eur J Hosp Pharm
; 30(3): 142-146, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103394
10.
A Pharmacological Review of Calcitonin Gene-Related Peptide Biologics and Future Use for Chronic Pain.
Cureus
; 15(2): e35109, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945265
11.
A Descriptive Survey Investigating the Impact of the COVID-19 Pandemic on the Public's Perception of Healthcare Professionals.
Cureus
; 15(7): e41703, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37575848
12.
Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del.
J Cyst Fibros
; 22(4): 607-614, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849331
13.
Ivacaftor: Five-year outcomes in the West of Scotland cystic fibrosis population.
Clin Respir J
; 17(5): 473-477, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36938952
14.
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.
Lancet Respir Med
; 11(6): 550-562, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36842446
15.
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.
Lancet Respir Med
; 10(3): 267-277, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942085
16.
Stepwise pathogenic evolution of Mycobacterium abscessus.
Science
; 372(6541)2021 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926925
17.
Salt and water balance after sweat loss: A study of Bikram yoga.
Physiol Rep
; 8(22): e14647, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230967
18.
Calcium loss in sweat does not stimulate PTH release: A study of Bikram hot yoga.
Complement Ther Med
; 51: 102417, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507433
19.
Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study.
ERJ Open Res
; 6(4)2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123558
20.
Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial.
PLoS One
; 15(12): e0242945, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33370348